发明授权
US07098015B2 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
有权
27875,22025,27420,17906,16319,55092和10218分子及其用途
- 专利标题： 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
- 专利标题（中）： 27875,22025,27420,17906,16319,55092和10218分子及其用途
-
申请号： US10386414申请日： 2003-03-11
-
公开(公告)号： US07098015B2公开(公告)日： 2006-08-29
- 发明人: Kyle J. MacBeth , Joseph M. Carroll , William James Cook , Rachel E. Meyers , Miyoung Chun , Mark J. Williamson
- 申请人： Kyle J. MacBeth , Joseph M. Carroll , William James Cook , Rachel E. Meyers , Miyoung Chun , Mark J. Williamson
- 申请人地址： US MA Cambridge
- 专利权人： Millennium Pharmaceuticals, Inc.
- 当前专利权人： Millennium Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Cambridge
- 代理机构： Millennium Pharmaceuticals Inc.
- 主分类号： C12N9/16
- IPC分类号： C12N9/16 ; C12N15/54 ; C12N15/62 ; C12N15/79
摘要：
The invention provides isolated nucleic acids molecules, designated 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 27875, 22025, 27420, 16319, 55092 and 10218 gene has been introduced or disrupted. The invention still further provides isolated 27875, 22025, 27420, 17906, 16319, 55092 or 10218 proteins, fusion proteins, antigenic peptides and anti-27875, 22025, 27420, 17906, 16319, 55092 or 10218 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
公开/授权文献
信息查询
